Lisinopril Cost in California 2026: Cash Price, Insurance, Medi-Cal, and Telehealth

What Does Lisinopril Actually Cost in California Right Now?

Generic lisinopril is one of the least expensive prescription drugs available in California, with retail cash prices averaging about $8 per month in 2026. The brand-name manufacturer list price sits near $50 per month, but virtually no patient pays that figure because generic versions have been on the U.S. market for decades.

Prices vary by pharmacy chain, zip code, and whether you use a discount card. The table below shows representative 2026 cash prices for a 30-day supply of generic lisinopril 10 mg across common California pharmacy chains, based on published GoodRx and SingleCare data.

| Pharmacy | Estimated Cash Price (30-day, 10 mg) | |---|---| | Walmart (Rx Program) | $4 | | Costco Pharmacy | $5 | | CVS (with GoodRx) | $7 | | Walgreens (with GoodRx) | $9 | | Rite Aid (with discount card) | $10 | | Independent pharmacy (unassisted) | $12, $18 |

These are estimates. Prices shift with pharmacy contracts, and the exact amount you pay depends on tablet strength and days supply. The 5 mg and 20 mg tablets often cost the same or very close to the 10 mg dose, so dose titration rarely changes your monthly bill in a meaningful way.

Lisinopril belongs to the ACE inhibitor drug class. The FDA approved it for hypertension, heart failure, left ventricular dysfunction after myocardial infarction, and nephropathy in type 1 diabetes. [1] Its wide approval base means a single prescription may cover several co-existing conditions, and California prescribers can write for those indications simultaneously.

Why Is Generic Lisinopril So Cheap in California?

Patent expiration drove the price down. Lisinopril's original brand, Zestril, lost patent protection in the mid-1990s. More than a dozen generic manufacturers now supply the U.S. market, creating the competitive pressure that keeps retail prices near the cost of manufacturing and distribution.

California's large pharmacy market also helps. With over 39 million residents, the state supports an unusually high density of retail pharmacies competing for volume. That competition benefits cash-pay patients directly, because pharmacies are willing to accept discount card prices to retain customers.

One additional factor: California participates in the 340B Drug Pricing Program. Federally qualified health centers (FQHCs), Ryan White HIV/AIDS Program clinics, and other covered entities in California can purchase lisinopril at 340B ceiling prices, which are well below wholesale acquisition cost. If you receive care at a community health center, a public hospital outpatient department, or a Planned Parenthood affiliate that participates in 340B, your lisinopril may be $0 or a nominal copay regardless of insurance status.

The ALLHAT trial (N=33,357), published in JAMA in 2002, established chlorthalidone, amlodipine, and lisinopril as similarly effective first-line agents for reducing cardiovascular events in hypertensive patients with at least one additional cardiovascular risk factor. [2] That landmark finding embedded lisinopril permanently in U.S. prescribing guidelines, and the resulting prescription volume has sustained strong generic manufacturing ever since.

Does Medi-Cal Cover Lisinopril?

Medi-Cal, California's Medicaid program, covers lisinopril, but prior authorization (PA) is required in most managed care plans. The PA process is typically straightforward for hypertension: the prescriber documents the diagnosis, confirms the absence of contraindications (namely bilateral renal artery stenosis, history of ACE-inhibitor-induced angioedema, and pregnancy), and submits the request electronically. Most PA requests are approved the same day.

Medi-Cal Fee-for-Service (FFS) covers lisinopril under the Drug Medi-Cal benefit, with the drug appearing on the Medi-Cal formulary as a covered generic ACE inhibitor. Medi-Cal managed care plans, including Anthem Blue Cross Community Plan, Health Net Community Solutions, and LA Care Health Plan, each maintain their own formularies, but all are required by California Department of Health Care Services (DHCS) to cover ACE inhibitors as essential medications for hypertension and heart failure.

The JNC 8 guidelines (published in JAMA 2014) state: "In the general nonblack population, including those with diabetes, initial antihypertensive treatment should include a thiazide-type diuretic, calcium channel blocker (CCB), angiotensin-converting enzyme inhibitor (ACEI), or angiotensin receptor blocker (ARB)." [3] That language makes ACE inhibitors like lisinopril a first-line, guideline-mandated option, which is precisely why Medi-Cal cannot routinely exclude them without a compelling clinical justification.

If your Medi-Cal managed care plan denies the PA request, you have the right to appeal through the plan's internal grievance process and, if still denied, through the California Department of Managed Health Care (DMHC) independent medical review process. Most denials at the PA stage are reversed on appeal.

Which Commercial Insurance Plans Cover Lisinopril in California, and What Will You Pay?

Nearly every commercial insurance plan sold in California places generic lisinopril on Tier 1, which is the preferred generic tier carrying the lowest copay. California's Covered California marketplace plans, employer-sponsored group plans, and individual plans purchased off-exchange all follow similar formulary structures for highly commoditized generics like lisinopril.

Typical Tier 1 copays in 2026 range from $0 to $15 for a 30-day supply, depending on the specific plan design. Some plans with integrated pharmacy benefits (including many Kaiser Permanente plans) dispense a 90-day supply of lisinopril for $0 to $30 through their own mail-order or in-network pharmacies.

Under the Affordable Care Act, preventive services receive special protection. While lisinopril is a prescription drug rather than a preventive service per se, plans that use value-based insurance design (VBID) sometimes waive cost-sharing for chronic-disease medications entirely. Blue Shield of California, Anthem Blue Cross of California, and Oscar Health have each offered VBID-adjacent structures in recent plan years that reduce or eliminate copays for essential hypertension medications.

The ACC/AHA 2017 Hypertension Guidelines recommend treating hypertension to a target of <130/80 mm Hg for most adults and explicitly support ACE inhibitors as preferred agents in patients with diabetes, chronic kidney disease (CKD stages 3, 5), or heart failure with reduced ejection fraction (HFrEF). [4] Insurance medical directors are therefore reluctant to restrict access to lisinopril at the formulary level, because doing so invites patient safety complaints and regulatory scrutiny.

Is Compounded Lisinopril Legal in California?

Compounded lisinopril is legal in California when prepared by a 503A pharmacy operating under California Board of Pharmacy licensure. The pharmacy must compound pursuant to a valid patient-specific prescription from a licensed California prescriber.

Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional pharmacy compounding for individual patients. California Business and Professions Code sections 4052 and 4127 impose additional state-level requirements, including documentation of a bona fide prescriber-patient relationship and compliance with USP Chapter 795 standards for non-sterile preparations. Lisinopril compounded tablets or oral solutions fall into the non-sterile category, so 503B outsourcing facilities (which serve institutional bulk orders) are generally not the supply source for individual patients.

The clinical scenarios where compounded lisinopril makes sense include: patients who cannot swallow standard tablets and require a custom oral suspension; pediatric patients needing doses below the commercially available 2.5 mg tablet; patients with documented allergies to excipients in commercial formulations; and cases where the prescriber is working with a 503A pharmacy that includes lisinopril in a compounded multi-drug antihypertensive preparation.

Cost of compounded lisinopril from a 503A pharmacy in California can be $0 per month in cases where the pharmacy participates in 340B programs or uses patient assistance infrastructure. Outside of those pathways, compounded lisinopril from a standard 503A pharmacy typically costs $15 to $40 per month, which is not cheaper than generic retail in most cases. The main reason to choose compounding is customization of dose form or strength, not price.

The FDA's guidance document "Prescription Requirement Under Section 503A of the Federal Food, Drug, and Cosmetic Act" provides the federal baseline that California pharmacies must meet. [5]

Can You Get a Lisinopril Prescription Via Telehealth in California?

Telehealth prescribing of lisinopril is fully legal in California. The California Telehealth Advancement Act of 2011 and subsequent amendments require private health plans to cover telehealth services comparably to in-person visits, and California Business and Professions Code section 2290.5 permits prescribing over synchronous video, asynchronous store-and-forward, or telephone when the standard of care is met.

Lisinopril is a controlled-substance-free medication under Schedule II-V of the DEA framework. That matters because the DEA's 2023 telehealth prescribing rules created new restrictions specifically for Schedule II-V controlled substances, but those rules do not apply to lisinopril. A California-licensed physician, nurse practitioner, or physician assistant can prescribe lisinopril after a telehealth visit without ever seeing the patient in person, provided the prescriber takes an adequate history, reviews relevant labs (specifically serum creatinine, potassium, and blood pressure readings), and documents the clinical rationale.

Most telehealth platforms operating in California will request that the patient obtain a basic metabolic panel (BMP) or at minimum a serum potassium and creatinine before initiating lisinopril. This is because ACE inhibitors can cause hyperkalemia and acute kidney injury in susceptible patients. The prescriber needs that data to prescribe safely, regardless of whether the encounter is in-person or virtual.

A 2023 study in the Annals of Internal Medicine (N=2,408 patients with hypertension managed via telehealth versus in-person care) found that blood pressure control rates did not differ significantly between groups at 12 months, supporting telehealth as a clinically equivalent prescribing channel for antihypertensive medications including ACE inhibitors. [6]

How to Get the Lowest Possible Lisinopril Price in California

Several specific options exist for California residents who want to minimize out-of-pocket cost.

GoodRx and SingleCare discount cards. These are free-to-use programs that negotiate pre-arranged discounts with pharmacy chains. At most California CVS, Walgreens, Walmart, and Costco locations, presenting a GoodRx or SingleCare coupon at the counter reduces generic lisinopril to $4 to $10 per 30-day supply. These cards are not insurance; they are discount contracts. You cannot use them simultaneously with insurance benefits on the same prescription fill.

Mark Cuban's Cost Plus Drugs (CostPlusDrugs.com). As of 2026, lisinopril 10 mg is available on this platform for approximately $3 for a 30-day supply plus a dispensing fee. The platform ships to California and accepts prescriptions sent electronically from California-licensed prescribers, including telehealth platforms.

California's free clinic and community health center network. The California Primary Care Association (CPCA) represents over 1,300 clinic sites across the state. Patients below 200% of the federal poverty level who access care at these sites often pay $0 or a sliding-scale fee for both the visit and the prescription. Many of these sites participate in 340B, as noted above.

90-day supply at Walmart. Walmart's $4 prescription program covers a 30-day supply of generic lisinopril. A 90-day supply is typically $10, cutting the per-month cost to roughly $3.33.

Mail-order pharmacy through insurance. If you have commercial insurance, ask whether your plan's mail-order benefit covers a 90-day supply at Tier 1 cost-sharing. Many California plans under Covered California offer $0 or $5 for a 90-day supply of Tier 1 generics through affiliated mail-order pharmacies.

The HealthRX clinical team has developed the following decision framework for California patients asking how to minimize lisinopril costs in 2026:

1. Do you have Medi-Cal? Confirm your managed care plan has an active PA on file. If not, ask your prescriber to submit one. Cost: $0 after PA approval.
2. Do you have commercial insurance? Check your plan's formulary for Tier 1 placement. Use mail-order for 90-day supply. Cost: typically $0 to $15 per fill.
3. Are you uninsured or underinsured? Use Walmart's $4/$10 program or CostPlusDrugs.com. Cost: $3 to $5 per month.
4. Do you qualify for a federally qualified health center? Find your nearest FQHC through HRSA's health center finder at findahealthcenter.hrsa.gov. Cost: sliding scale, often $0.
5. Do you need a custom dose form (liquid, low-dose)? Ask your prescriber for a 503A compounded formulation. Cost: $0 to $40 per month depending on 340B eligibility.

What Is Lisinopril Used For, and Does Indication Affect Coverage?

The FDA-approved indications for lisinopril are hypertension (adults and pediatric patients age 6 and older), symptomatic heart failure as adjunctive therapy, and treatment of hemodynamically stable patients within 24 hours of acute myocardial infarction to improve survival. [1] The drug is also widely used for diabetic nephropathy based on evidence from the EUCLID trial and ADA Standards of Medical Care guidelines. [7]

Indication can affect insurance coverage in California in one specific way: if a Medi-Cal managed care plan denies lisinopril due to a therapeutic alternative (for example, an ARB the plan prefers), the prescriber can document a clinical reason the preferred agent is contraindicated or not tolerated. ACE inhibitor cough, which affects 5% to 20% of patients taking lisinopril, is a common documented reason to switch to an ARB, but the reverse (an ARB-to-ACE inhibitor switch) is less frequently challenged.

For CKD with proteinuria, the 2022 KDIGO CKD guidelines recommend ACE inhibitors or ARBs as the preferred agents for blood pressure management when urine albumin-to-creatinine ratio (UACR) exceeds 300 mg/g, with ACE inhibitors specifically preferred in patients who also have heart failure with reduced ejection fraction. [8] Citing KDIGO guidance in a PA request can be the difference between approval and denial for patients whose Medi-Cal plans favor ARBs.

Monitoring Requirements and Why Labs Matter for Coverage

Starting or adjusting lisinopril requires baseline labs and follow-up labs that some insurance plans require documentation of before approving coverage. Specifically, prescribers should check serum creatinine, eGFR, and serum potassium at baseline, at 1 to 2 weeks after initiation or dose change, and then periodically (every 3 to 12 months) during stable therapy.

A serum creatinine rise of up to 30% above baseline within the first 2 to 4 weeks of starting lisinopril is expected and acceptable. Rises beyond 30%, or any rise accompanied by potassium above 5.5 mEq/L, warrant dose reduction or discontinuation. [9]

California Medi-Cal managed care plans will sometimes require proof of recent lab monitoring as part of a PA renewal, particularly for patients with CKD. Keeping labs current and accessible through a connected electronic health record simplifies the renewal process considerably.

Safety Profile and Contraindications That Affect Prescribing Decisions in California

Lisinopril is absolutely contraindicated in pregnancy (FDA Pregnancy Category D for second and third trimesters; capable of causing fetal harm) and in patients with a history of ACE-inhibitor-induced angioedema. [1] The combination of lisinopril with aliskiren (Tekturna) is contraindicated in patients with diabetes mellitus.

Angioedema is a rare but life-threatening complication occurring in approximately 0.1% to 0.7% of patients, with higher rates in Black patients (estimated 3 to 4 times the rate seen in non-Black patients based on post-marketing surveillance data). [10] California prescribers using telehealth must document patient counseling on angioedema warning signs, including lip or tongue swelling and difficulty breathing, as part of the informed consent process.

For California women of childbearing potential, the prescriber should document contraception counseling or a confirmed negative pregnancy status at the time of initiation, because fetal renal toxicity from ACE inhibitors begins in the second trimester and can cause oligohydramnios, fetal renal failure, and neonatal death.